JUPITER, Fla., March 14, 2012 /PRNewswire/ -- Dyadic International, Inc. ("Dyadic") (OTC Pink: DYAI), a global biotechnology company focused on the discovery, development, manufacture and sale of enzyme and protein products for the industrial enzyme, bioenergy, and biopharmaceutical industries, announced today that it will launch FibreZyme® G5000, a next generation, high performance powder enzyme designed to improve paper quality and improve the economics of various pulp and paper manufacturing processes, in Booth #1065 at the Tissue World Americas conference and exhibition being held at the Miami Beach Convention Center in Miami, Florida from March 20th to March 23rd, 2012.
Thomas O'Shaughnessy, Vice President Sales & Marketing stated, "FibreZyme® G5000 is a great addition to our current FibreZyme® series of products and provides further evidence of the value-adding capabilities of Dyadic's C1 platform technology. FibreZyme® G5000 operates under wide pH and temperature ranges allowing for seamless integration into most pulp and paper manufacturing processes."
Specific attributes of FibreZyme® G5000 include the following:
FibreZyme® G5000 is produced using a variant of Dyadic's patented and proprietary C1 platform technology which Dyad
|SOURCE Dyadic International, Inc.|
Copyright©2010 PR Newswire.
All rights reserved